n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine: a zinc ion chelating agent; structure given in first source
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine : An N-substituted diamine that is ethylenediamine in which the four amino hydrogens are replaced by 2-pyridylmethyl groups.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zalewski, PD | 2 |
Forbes, IJ | 2 |
Betts, WH | 1 |
Giannakis, C | 1 |
2 other studies available for n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and B-Cell Chronic Lymphocytic Leukemia
Article | Year |
---|---|
Correlation of apoptosis with change in intracellular labile Zn(II) using zinquin [(2-methyl-8-p-toluenesulphonamido-6-quinolyloxy)acetic acid], a new specific fluorescent probe for Zn(II).
Topics: Animals; Apoptosis; Chelating Agents; DNA Damage; Ethylenediamines; Fluorescent Dyes; Humans; Kineti | 1993 |
Physiological role for zinc in prevention of apoptosis (gene-directed death).
Topics: Cations, Divalent; Cell Death; Chelating Agents; Chromatography, Gel; Colchicine; DNA; Ethylenediami | 1991 |